Tatva Chintan Pharma Chem IPO listing price is ₹ 2310.25, issue price is [●], and currently trading at ₹ 920.55 as on May 22, 2025. Tatva Chintan Pharma Chem IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Tatva Chintan Pharma Chem IPO is a Book Building listing on BSE,NSE exchange. The company is based in Bharuch and caters to Chemical - Speciality sector. ICICI Securities , Jm Financial are the merchant bankers of Tatva Chintan Pharma Chem IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on [●].
Tatva Chintan Pharma Chem IPO offer price is ₹ 1083.00 and got listed at ₹ 2310.25. Read Tatva Chintan Pharma Chem IPO details mentioned above.The IPO of Tatva Chintan Pharma Chem Limited was listed on 29th July 2021. As of today, Tatva Chintan Pharma Chem IPO is trading at ₹ 920.55, compared to the previous day’s close of ₹ 965.85. Read the report above for detailed IPO performance.
The issue price of Tatva Chintan Pharma Chem IPO was [●] per equity share.
Tatva Chintan Pharma Chem IPO was listed at ₹2310.25 on the stock exchange on 29th July 2021. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of May 22, 2025, the current market price of Tatva Chintan Pharma Chem IPO is ₹ 920.55.
The 52-week high for Tatva Chintan Pharma Chem IPO is ₹ 1222.00, while the 52-week low is ₹ 621.00. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Tatva Chintan Pharma Chem IPO listed at ₹ 2310.25 against the issue price of [●] per equity share, showing a listing day gain/loss of 1227.25 (113.32%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Tatva Chintan Pharma Chem IPO stock moved from its listing price of ₹ 2310.25 to the current price of ₹920.55 per equity share, reflecting a change of -60.15% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Tatva Chintan Pharma Chem IPO issue date of May 22, 2025 and CMP of ₹920.55, the estimated CAGR is approximately -4.16%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Tatva Chintan Pharma Chem IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Tatva Chintan Pharma Chem Financial Review Page
Merchant Banker(s) of Tatva Chintan Pharma Chem IPO: ICICI Securities Limited , Jm Financial Limited
Tatva Chintan Pharma Chem IPO subscription was 180.36 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Tatva Chintan Pharma Chem IPO listed at a listing price of 2310.25 against the offer price of 1083.00.
The current market price of Tatva Chintan Pharma Chem is 920.55.
Why Us?